• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol Methods . Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages

tetano

Editor, Senior Moderator
J Virol Methods


. 2020 Aug 8;113947.
doi: 10.1016/j.jviromet.2020.113947. Online ahead of print.
Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages


Lauren Garnett[SUP] 1 [/SUP], Alexander Bello[SUP] 2 [/SUP], Kaylie N Tran[SUP] 2 [/SUP], Jonathan Audet[SUP] 2 [/SUP], Anders Leung[SUP] 2 [/SUP], Zachary Schiffman[SUP] 3 [/SUP], Bryan D Griffin[SUP] 2 [/SUP], Nikesh Tailor[SUP] 2 [/SUP], Darwyn Kobasa[SUP] 3 [/SUP], James E Strong[SUP] 4 [/SUP]



Affiliations

Abstract

On March 11, 2020, the World Health Organization (WHO) assessed COVID-19, caused by SARS-CoV-2, as a pandemic. As of June 1, 2020, SARS-CoV-2 has had a documented effect of over 6 million cases world-wide, amounting to over 370,000 deaths (World Health Organization, 2020. Novel Coronavirus (COVID-19) Situation. http://https://covid19.who.int/). Consequently, the high demand for testing has resulted in a depletion of commercially available consumables, including the recommended swabs and viral transport media (VTM) required for nasopharyngeal sampling. Therefore, the potential use of unvalidated alternatives must be explored to address the global shortage of testing supplies. To tackle this issue, we evaluated the utility of different swabs and transport mediums for the molecular detection of SARS-CoV-2. This study compared the performance of six swabs commonly found in primary and tertiary health care settings (PurFlock Ultra, FLOQSwab, Puritan Pur-Wraps cotton tipped applicators, Puritan polyester tipped applicators, MedPro 6" cotton tipped applicators, and HOLOGIC Aptima) for their efficacy in testing for SARS-CoV-2. Separately, the molecular detection of SARS-CoV-2 was completed from different transport mediums (DMEM, PBS, 100 % ethanol, 0.9 % normal saline and VTM), which were kept up to three days at room temperature (RT). The results indicate that there is no meaningful difference in viral yield from different swabs and most transport mediums for the collection and detection of SARS-CoV-2, indicating swab and medium alternatives could be used if supplies run out.

Keywords: Diagnostic testing; SARS-CoV-2; Swab.
 
Back
Top Bottom